Herein, we presented that compared with relapsing patients, the proportion of immunosuppressive cells’ Tregs was decreased and the proportion of CD3–CD56+ NK cells which can exert detrimental effects to cancer cells was increased in those achieving good clinical results after de‐escalating or discontinuing, these results were consistent with the EUROSKI [17]. Here, NCAM1 is linked to cancer.